# Takeda

> Transforming lives through science

Business model and tags: B2B, Has physical offices, Publicly traded, Manufacturing, Multi-product, Sales-led purchase, Pharma & life sciences, Sells to enterprises, Multi-site, International operations, Has production sites, Has in-house R&D, Has a works council, Handles regulated data

## About Takeda

The company is committed to transforming lives by advancing science, focusing on patient needs, and setting new standards in healthcare

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 10,000+ employees
- **Headquarters**: Minato City, Tokyo, Japan
- **Founded**: 1781
- **Revenue**: JPY 4506B (FY2026, publicly reported)
- **Website**: [takeda.com](https://www.takeda.com/)
- **LinkedIn**: [linkedin.com/company/takeda-pharmaceuticals](https://www.linkedin.com/company/takeda-pharmaceuticals)

## Takeda competitors

- [Pfizer](https://www.tamtam.ai/c/pfizer) (pfizer.com): Developing innovative healthcare therapies · United States · 10,000+ employees · Direct competitor
- [Novartis](https://www.tamtam.ai/c/novartis) (novartis.com): Developing innovative medicines · Switzerland · 10,000+ employees · Direct competitor
- [Roche](https://www.tamtam.ai/c/roche) (roche.com): Personalized healthcare and innovation · Switzerland · 10,000+ employees · Direct competitor
- Otsuka Holdings Co., Ltd. (otsuka.com:443): Tokyo-based services provider · Japan · 51–250 employees · Direct competitor
- [Merck](https://www.tamtam.ai/c/merck) (merck.com): Leading-edge science saves lives · United States · 10,000+ employees · Direct competitor
- [Chugai Pharmaceutical Co., Ltd.](https://www.tamtam.ai/c/chugai-pharmaceutical-co-ltd) (chugai-pharm.co.jp): Pharmaceutical research and development · Japan · 1,001–5,000 employees · Direct competitor

[See all 36 competitors](https://www.tamtam.ai/c/takeda/competitors)

## Takeda lookalikes

- [Johnson&Johnson](https://www.tamtam.ai/c/johnson-and-johnson) (jnj.com): Global Healthcare Innovation Leader · United States · 10,000+ employees · 99% similar
- [Roche](https://www.tamtam.ai/c/roche) (roche.com): Personalized healthcare and innovation · Switzerland · 10,000+ employees · 99% similar
- [Pfizer](https://www.tamtam.ai/c/pfizer) (pfizer.com): Developing innovative healthcare therapies · United States · 10,000+ employees · 99% similar
- [Sanofi](https://www.tamtam.ai/c/sanofi) (sanofi.com): AI-powered biopharma company · France · 10,000+ employees · 99% similar
- [Novartis](https://www.tamtam.ai/c/novartis) (novartis.com): Developing innovative medicines · Switzerland · 10,000+ employees · 99% similar
- [AstraZeneca](https://www.tamtam.ai/c/astrazeneca) (astrazeneca.com): Healthcare innovation through science · United Kingdom · 10,000+ employees · 99% similar

[See all 30 lookalikes](https://www.tamtam.ai/c/takeda/lookalikes)

## Jobs at Takeda

- [Procurement Experience Agent (Maternity cover)](https://www.linkedin.com/jobs/view/4486608918/) · Lodz Metropolitan Area, Poland · Nov 7, 2026
- [Lead Counsel, Foundational Therapeutics Platform Business Unit and Insights & Analytics](https://www.linkedin.com/jobs/view/4486660035/) · Boston, MA, United States · Nov 7, 2026
- [Global Insights Lead, Neuroscience Assets & Programs](https://www.linkedin.com/jobs/view/4485854292/) · Cambridge, MA, United States, Remote · Nov 5, 2026

[See all 40 openings](https://www.tamtam.ai/c/takeda/jobs)

## Takeda in the news

- [Reflecting on Progress in Post-Transplant Care and CMV](https://www.takeda.com/our-impact/our-stories/progress-transplant-care/) · takeda.com · Nov 19, 2026
  Post-transplant patients face challenges like managing a suppressed immune system and cytomegalovirus (CMV), which can cause serious complications.
- [FDA approves Orzeyful for narcolepsy type 1 in adults | AASM](https://aasm.org/takeda-launches-orzeyful-for-adults-with-narcolepsy-type-1/) · aasm.org · Nov 18, 2026
  Orzeyful is a new FDA-approved prescription drug for narcolepsy type 1 in adults, targeting the underlying orexin deficiency.
- [Takeda stock: Bank of America reiterates Buy rating](https://www.ad-hoc-news.de/boerse/news/corporate-news/takeda-stock-bank-of-america-reiterates-buy-rating/70525601) · ad-hoc-news.de · Nov 17, 2026
  Bank of America Securities reiterated a Buy rating on Takeda, setting a price target of 8,000 yen.

[See all 20 articles](https://www.tamtam.ai/c/takeda/news)

## Takeda at a glance

Takeda is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Minato City, Tokyo, Japan.

Takeda was founded in 1781.

Takeda has 10,000+ employees.

Takeda's revenue is JPY 4506B (FY2026, publicly reported).

Takeda is hiring: 40 recent open roles, including Procurement Experience Agent (Maternity cover), Lead Counsel, Foundational Therapeutics Platform Business Unit and Insights & Analytics, Global Insights Lead, Neuroscience Assets & Programs.

## Frequently asked questions about Takeda

### What is Takeda's revenue?

Takeda's revenue is JPY 4506B (FY2026, publicly reported).

### How many employees does Takeda have?

Takeda has 10,000+ employees.

### Where is Takeda headquartered?

Takeda is headquartered in Minato City, Tokyo, Japan.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/takeda
